About Enzymotec
Enzymotec is a company based in Kfar Saba (Israel) founded in 1998 was acquired by Frutarom in October 2017. Enzymotec has raised $21 million across 3 funding rounds from investors including Frutarom, TPY Capital and Ofer-Hi Tech. Enzymotec has completed 1 acquisition, including Union Springs Healthcare. Enzymotec operates in a competitive market with competitors including Advanced Enzyme Technologies, The DuPont Nutrition and Health, Zivo Bioscience, Kaffe Bueno and Zarbees, among others.
- Headquarter Kfar Saba, Israel
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Enzymotec
Enzymotec has successfully raised a total of $21M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $12.9 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Enzymotec
Enzymotec has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Frutarom, TPY Capital and Ofer-Hi Tech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Traditional company manufacturing flavor and fine ingredients
|
Locked | Locked | Locked |
Investor details for Enzymotec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enzymotec
Enzymotec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Union Springs Healthcare.
Investment portfolio details for Enzymotec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Natural, therapeutically-validated products are developed for mainstream medicine.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Enzymotec
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Enzymotec
Detailed financials for Enzymotec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enzymotec Comparisons
Peer comparison for Enzymotec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enzymotec
Enzymotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Enzyme Technologies, The DuPont Nutrition and Health, Zivo Bioscience, Kaffe Bueno and Zarbees, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Enzymes are manufactured for nutrition, food, feed, and textile industries.
|
|
| Locked | Locked | Locked |
Manufactures a range of health ingredients
|
|
| Locked | Locked | Locked |
Bioactive compounds from algal strain
|
|
| Locked | Locked | Locked |
Coffee beans are supplied by Kaffe Bueno in multiple categories.
|
|
| Locked | Locked | Locked |
Natural cough remedies and wellness products are developed by Zarbees.
|
Detailed competitors of Enzymotec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enzymotec
Complete news archive for Enzymotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enzymotec
Enzymotec was founded in 1998 and raised its 1st funding round 11 years after it was founded.
Enzymotec is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.
Enzymotec is a funded company, having raised a total of $21M across 3 funding rounds to date.
Enzymotec develops and produces biofunctional ingredients to address health needs associated with the human life cycle, starting from babies up to seniors. It develops, manufactures and markets bio-functional lipid ingredients, as well as final products, based on proprietary processes and technologies. Offerings encompass two segments - Nutrition ingredients for infant formulas and dietary supplements (sold through Advanced Lipids, our joint venture with AAK) and branded lipid-based medical foods for the dietary management of medical disorders and phospholipid-based bioactive ingredients for nutritional supplements. Other nutritional ingredients include krill oil and dietary supplements targeted at improving brain health providing benefits in memory, learning abilities and concentration. Enzymotec subsidiary Vaya Pharma manufactures lipid-based products for addressing dietary issues in Attention Deficit Hyperactivity Disorder (ADHD) and Hypertriglyceridemia.
Enzymotec's top competitors include Advanced Enzyme Technologies, Zivo Bioscience and The DuPont Nutrition and Health.
Enzymotec has made 1 acquisition, including Union Springs Healthcare.
Enzymotec has 6 investors. Key investors include Frutarom, TPY Capital, Ofer-Hi Tech, Millennium Materials Technologies Fund, and Arancia.